South Texas Accelerated Research Therapeutics — San Antonio, Texas

South Texas Accelerated Research Therapeutics is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics has participated in 167 clinical trials with 34 currently active.

Therapeutic areas: Advanced Nonhematological Malignancies, Solid Tumor, Carcinoma, Non-Small-Cell Lung.

Sponsors: Millennium Pharmaceuticals, Inc., Livzon Pharmaceutical Group Inc., Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Antonio

Browse all research sites in Texas · View every site in San Antonio

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics?

South Texas Accelerated Research Therapeutics has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics conducted?

South Texas Accelerated Research Therapeutics has 167 clinical trials on record, with 34 currently active. Their work covers Advanced Nonhematological Malignancies, Solid Tumor, Carcinoma, Non-Small-Cell Lung.

Is South Texas Accelerated Research Therapeutics accredited by Crixeo Clinical Trials?

South Texas Accelerated Research Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.